JP2010501595A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010501595A5 JP2010501595A5 JP2009525861A JP2009525861A JP2010501595A5 JP 2010501595 A5 JP2010501595 A5 JP 2010501595A5 JP 2009525861 A JP2009525861 A JP 2009525861A JP 2009525861 A JP2009525861 A JP 2009525861A JP 2010501595 A5 JP2010501595 A5 JP 2010501595A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- antigen
- inducing
- adjuvant
- adjuvants
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000002671 adjuvant Substances 0.000 claims 12
- 239000000203 mixture Substances 0.000 claims 10
- 239000000427 antigen Substances 0.000 claims 8
- 102000036639 antigens Human genes 0.000 claims 8
- 108091007433 antigens Proteins 0.000 claims 8
- 230000001939 inductive effect Effects 0.000 claims 6
- 230000028993 immune response Effects 0.000 claims 5
- 241001465754 Metazoa Species 0.000 claims 4
- 230000003308 immunostimulating effect Effects 0.000 claims 3
- 206010028980 Neoplasm Diseases 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 244000052769 pathogen Species 0.000 claims 2
- 230000002685 pulmonary effect Effects 0.000 claims 2
- 108091034117 Oligonucleotide Proteins 0.000 claims 1
- 239000000443 aerosol Substances 0.000 claims 1
- AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical class [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 claims 1
- 239000002158 endotoxin Substances 0.000 claims 1
- 229920006008 lipopolysaccharide Polymers 0.000 claims 1
- 239000002502 liposome Substances 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 239000000825 pharmaceutical preparation Substances 0.000 claims 1
- 229940127557 pharmaceutical product Drugs 0.000 claims 1
- 239000000843 powder Substances 0.000 claims 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 claims 1
- 229930182490 saponin Natural products 0.000 claims 1
- 150000007949 saponins Chemical class 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2006904796 | 2006-09-01 | ||
| AU2006904796A AU2006904796A0 (en) | 2006-09-01 | Method of Eliciting or Inducing an Immune Response | |
| PCT/AU2007/001277 WO2008025095A1 (en) | 2006-09-01 | 2007-08-31 | Method of eliciting or inducing an immune response |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2010501595A JP2010501595A (ja) | 2010-01-21 |
| JP2010501595A5 true JP2010501595A5 (enExample) | 2010-09-16 |
| JP5265545B2 JP5265545B2 (ja) | 2013-08-14 |
Family
ID=39135429
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009525861A Expired - Fee Related JP5265545B2 (ja) | 2006-09-01 | 2007-08-31 | 免疫応答を誘発または誘導する方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US9150619B2 (enExample) |
| EP (1) | EP2066341B1 (enExample) |
| JP (1) | JP5265545B2 (enExample) |
| KR (1) | KR20090064412A (enExample) |
| CN (1) | CN101522213A (enExample) |
| AU (1) | AU2007291887B2 (enExample) |
| CA (1) | CA2662164A1 (enExample) |
| DK (1) | DK2066341T3 (enExample) |
| ES (1) | ES2547855T3 (enExample) |
| NZ (1) | NZ575141A (enExample) |
| WO (1) | WO2008025095A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001037869A1 (en) * | 1999-11-19 | 2001-05-31 | Csl Limited | Vaccine compositions |
| CA2700937C (en) * | 2007-10-12 | 2017-05-09 | Csl Limited | Method of eliciting an immune response against pandemic influenza virus |
| EP2501396B1 (en) * | 2009-11-18 | 2018-04-25 | Auburn University | Low antigen-dose immunization for maximizing t-helper cell 1 (th1) immunity against disease |
| US10006096B2 (en) * | 2012-03-27 | 2018-06-26 | Variation Biotechnologies Inc. | Methods for detection of anti-cytomegalovirus neutralizing antibodies |
| WO2019020493A1 (en) * | 2017-07-27 | 2019-01-31 | Medi-Immune Limited | VACCINE COMPOSITIONS |
| GB2564901B (en) * | 2017-07-27 | 2020-04-08 | Medi Immune Ltd | Vaccine compositions |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9326253D0 (en) * | 1993-12-23 | 1994-02-23 | Smithkline Beecham Biolog | Vaccines |
| WO1999052547A1 (en) * | 1998-04-13 | 1999-10-21 | Brigham Women's Hospital, Inc. | Vaccine compositions comprising cd-1 antigens and t-cell stimulating compound and methods of use thereof |
| EP0976403A1 (en) * | 1998-07-30 | 2000-02-02 | Stichting Instituut voor Dierhouderij en Diergezondheid (ID-DLO) | Adjuvant comprising pulmonary surfactant |
| TWI310688B (en) | 1999-10-29 | 2009-06-11 | Nektar Therapeutics | Dry powder compositions having improved dispersivity |
| US20020044951A1 (en) * | 2000-04-04 | 2002-04-18 | Gui Liu | Isolated and purified nonpeptide antigens from mycobacterium tuberculosis |
| CA2411965A1 (en) | 2000-06-16 | 2001-12-20 | Sembiosys Genetics Inc. | The use of plant oil-bodies in vaccine delivery systems |
| GB0021757D0 (en) * | 2000-09-04 | 2000-10-18 | Colaco Camilo | Vaccine against microbial pathogens |
| DE10044622A1 (de) * | 2000-09-09 | 2002-03-21 | Krupp Corpoplast Maschb Gmbh | Vorrichtung zur Herstellung von Vorformlingen |
| US20030190333A1 (en) * | 2002-02-04 | 2003-10-09 | Corixa Corporation | Immunostimulant compositions comprising aminoalkyl glucosaminide phosphates and saponins |
| GB0401239D0 (en) | 2004-01-21 | 2004-02-25 | Molecularnature Ltd | Adjuvant compositions |
| TWI277032B (en) * | 2004-02-27 | 2007-03-21 | Au Optronics Corp | Planar display module |
| MXPA06012838A (es) | 2004-05-07 | 2007-05-15 | Harvard College | Vacuna de malaria pulmonar. |
-
2007
- 2007-08-31 CN CNA200780035181XA patent/CN101522213A/zh active Pending
- 2007-08-31 US US12/439,054 patent/US9150619B2/en active Active
- 2007-08-31 KR KR1020097006683A patent/KR20090064412A/ko not_active Ceased
- 2007-08-31 ES ES07800235.9T patent/ES2547855T3/es active Active
- 2007-08-31 CA CA002662164A patent/CA2662164A1/en not_active Abandoned
- 2007-08-31 NZ NZ575141A patent/NZ575141A/en not_active IP Right Cessation
- 2007-08-31 JP JP2009525861A patent/JP5265545B2/ja not_active Expired - Fee Related
- 2007-08-31 WO PCT/AU2007/001277 patent/WO2008025095A1/en not_active Ceased
- 2007-08-31 AU AU2007291887A patent/AU2007291887B2/en not_active Ceased
- 2007-08-31 EP EP07800235.9A patent/EP2066341B1/en active Active
- 2007-08-31 DK DK07800235.9T patent/DK2066341T3/en active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010501595A5 (enExample) | ||
| WO2010037395A3 (en) | Mhc multimers in cancer vaccines and immune monitoring | |
| WO2009089535A3 (en) | Polypeptide vaccine and vaccination strategy against mycobacterium | |
| JP2011518170A5 (enExample) | ||
| HRP20160816T1 (hr) | Upotreba virusa influence i emulzije ulja u vodi kao adjuvansa radi poticanja t-stanica cd4 i/ili poboljšanog odgovora memorijskih b-stanica | |
| NZ711518A (en) | Multivalent glycoconjugate vaccines | |
| WO2009039854A8 (en) | Mhc multimers in tuberculosis diagnostics, vaccine and therapeutics | |
| JP2007211026A5 (enExample) | ||
| RU2017137357A (ru) | Быстрорастворяющаяся лекарственная форма пероральной вакцины, в которой используют крахмал | |
| HRP20150177T1 (hr) | Cjepivo protiv tuberkuloze i postupak upotrebe tog cjepiva | |
| WO2008054535A3 (en) | Novel influenza m2 vaccines | |
| WO2013082535A3 (en) | Controlled-release peptide compositions and uses thereof | |
| JP2018501322A5 (enExample) | ||
| WO2007146359A3 (en) | Sea lice antigen vaccines | |
| JP2008539169A5 (enExample) | ||
| WO2008028667A3 (en) | Use of glycolipids as adjuvants | |
| WO2005056769A3 (en) | Orally-administered live bacterial vaccines for plague | |
| JP2018043942A5 (enExample) | ||
| ES2436344B1 (es) | Composición farmacéutica de diacetilmorfina y naloxona para administración oral | |
| Yao et al. | SOCS1 and SOCS3 are targeted by hepatitis C virus core/gC1qR ligation to inhibit T-cell function | |
| Pilishvili | Changes in invasive pneumococcal disease (IPD) following 5 years of 13-valent pneumococcal conjugate vaccine use in the US | |
| CN302498376S (zh) | 中医封包综合治疗仪（ab3型） | |
| JP2009126813A5 (enExample) | ||
| Dougan | A single-dose, live oral typhoid vaccine: an achievable goal? | |
| CN302438610S (zh) | 椅子（ct—393） |